Biotech: Angelini Ventures Leads €20 Million Financing Round for NeumirnaNeumirna Therapeutics: Pioneering RNA-Based Therapies for Neurological Disorders Published On 18 January 2025 In Startup Technologies Neumirna Therapeutics, a Danish biotechnology company specializing in RNA-based therapies for next-generation treatments... By Editorial Staff
